Home > News > Atoms, molecules and medicine
February 9th, 2005
Atoms, molecules and medicine
Karen Arnold is not your typical engineer. For one thing, she’s a woman (a whopping 91 percent of engineers are male). For another, she’s an entrepreneur—of the venture capitalist variety, to boot. Arnold is also cofounder and the chief financial officer of Nanocopoeia, Inc., a biotechnology firm that has recently transitioned from startup to full-fledged product development mode.
The St. Paul-based firm, founded in 2001, is working with pharmaceutical companies to develop new ways to deliver medications to patients using nanotechnology.
Arrowhead Presents Phase 1 Data on ARC-520 at HepDART 2013 December 9th, 2013
Recycled Plastic Proves Effective in Killing Drug-Resistant Fungi: IBN and IBM discover new medical application for converted PET bottles December 9th, 2013
Scientists Mulling Possibility of Using Nanostructured Bioceramics to Repair Bone Tissue December 9th, 2013
Nanobiotix strengthens its NanoXray pipeline with the launch of NBTX-TOPO development, the first nanotherapeutic with embedded radar: 1 product, 2 skills December 6th, 2013
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010